Li Y, Lan J, Wong G
Biosaf Health. 2025; 5(5):272-279.
PMID: 40078910
PMC: 11895002.
DOI: 10.1016/j.bsheal.2023.08.003.
Chae D, Park H, Kim K, Yu A, Park J, Oh M
Exp Mol Med. 2025; .
PMID: 40025168
DOI: 10.1038/s12276-025-01416-1.
Quinn A, Zhao L, Bell S, Huq M, Fang Y
Int J Mol Sci. 2025; 26(4).
PMID: 40004141
PMC: 11855143.
DOI: 10.3390/ijms26041678.
Abu-Helu R, Zeer M, Adwan G
J Pathog. 2025; 2024:1051658.
PMID: 39995847
PMC: 11850064.
DOI: 10.1155/2024/1051658.
Gao L, Xu Z, Hu J, Zhang Q, Fu S, Wang W
Sci Rep. 2025; 15(1):6417.
PMID: 39984588
PMC: 11845713.
DOI: 10.1038/s41598-025-91042-8.
Analysis of differential expression of matrix metalloproteinases and defensins in the nasopharyngeal milieu of mild and severe COVID-19 cases.
Imtiaz K, Farooqui N, Ahmed K, Zhamalbekova A, Anwar M, Nasir A
PLoS One. 2025; 20(2):e0304311.
PMID: 39965032
PMC: 11835293.
DOI: 10.1371/journal.pone.0304311.
Durability of Functional SARS-CoV-2-Specific Immunological Memory and T Cell Response up to 8-9 Months Postrecovery From COVID-19.
Trimbake D, Singh D, K Y, Babar P, S V, Tripathy A
J Immunol Res. 2025; 2025:9743866.
PMID: 39963186
PMC: 11832264.
DOI: 10.1155/jimr/9743866.
Different immunological characteristics of asymptomatic and symptomatic COVID-19 patients without vaccination in the acute and convalescence stages.
Li L, Zhang X, Yan H, Dai M, Gao H, Wang Y
PeerJ. 2025; 13:e18451.
PMID: 39897496
PMC: 11786710.
DOI: 10.7717/peerj.18451.
Genetic diversity of the immunoglobulin heavy chain locus in cohorts of patients affected with SARS-CoV-2.
Malaspina P, Jodice C, Ciminelli B, Biancolella M, Colona V, Latini A
Hum Genomics. 2025; 19(1):7.
PMID: 39885568
PMC: 11780896.
DOI: 10.1186/s40246-025-00719-8.
Ovarian function after COVID-19: long-term effects and vaccine safety in ART patients.
Herrero Y, Velazquez C, Pascuali N, Hauk V, de Zuniga I, Martinez G
J Assist Reprod Genet. 2025; 42(2):563-576.
PMID: 39883303
PMC: 11871259.
DOI: 10.1007/s10815-025-03403-x.
A20 as a Potential Therapeutic Target for COVID-19.
Wu Y, He L, Li R, Li J, Zhao Q, Shao B
Immun Inflamm Dis. 2025; 13(1):e70127.
PMID: 39853876
PMC: 11760982.
DOI: 10.1002/iid3.70127.
Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levels.
Snyder T, Gittelman R, Klinger M, May D, Osborne E, Taniguchi R
Front Immunol. 2025; 15():1488860.
PMID: 39840037
PMC: 11747429.
DOI: 10.3389/fimmu.2024.1488860.
CXCL12 ameliorates neutrophilia and disease severity in SARS-CoV-2 infection.
Zheng J, Dhakal H, Qing E, Shrestha R, Geller A, Morrissey S
J Clin Invest. 2025; 135(4).
PMID: 39773555
PMC: 11827850.
DOI: 10.1172/JCI188222.
Can there be calm during a cytokine storm? Immune checkpoint pathways affecting the severity of COVID-19 disease.
Meggyes M, Nagy D, Toth I, Feik T, Peterfalvi A, Polgar B
Front Microbiol. 2025; 15:1508423.
PMID: 39764446
PMC: 11700970.
DOI: 10.3389/fmicb.2024.1508423.
IL-1β-driven NF-κB transcription of ACE2 as a Mechanism of Macrophage Infection by SARS-CoV-2.
Lee C, Khan R, Mantsounga C, Sharma S, Pierce J, Amelotte E
bioRxiv. 2025; .
PMID: 39763770
PMC: 11703209.
DOI: 10.1101/2024.12.24.630260.
SARS-CoV-2 infection and risk of subsequent demyelinating diseases: national register-based cohort study.
Montgomery S, Vingeliene S, Li H, Backman H, Udumyan R, Jendeberg J
Brain Commun. 2024; 6(6):fcae406.
PMID: 39659973
PMC: 11629974.
DOI: 10.1093/braincomms/fcae406.
Immunophenotyping characteristics and clinical outcome of COVID-19 patients treated with azvudine during the Omicron surge.
Qiu M, Song X, Zhang Q, Zou S, Pang L, Nian X
Front Immunol. 2024; 15:1465238.
PMID: 39654887
PMC: 11625784.
DOI: 10.3389/fimmu.2024.1465238.
Novel insights into the ROCK-JAK-STAT signaling pathway in upper respiratory tract infections and neurodegenerative diseases.
Li J, Mao N, Wang Y, Deng S, Chen K
Mol Ther. 2024; 33(1):32-50.
PMID: 39511889
PMC: 11764622.
DOI: 10.1016/j.ymthe.2024.11.011.
Association Between the Use of Proton Pump Inhibitors and Severe Clinical Outcomes in COVID-19 Patients: A Retrospective Observational Study.
Pinto S, Al Lawati H, Al Raisi M, Maawali B
Cureus. 2024; 16(10):e72385.
PMID: 39463908
PMC: 11510648.
DOI: 10.7759/cureus.72385.
Case-control study on risk factors for in-hospital mortality in patients with severe COVID-19.
Wu K, Yin L, Han J, Cai Q, Guo Y, Jin X
Front Public Health. 2024; 12:1424720.
PMID: 39440172
PMC: 11493594.
DOI: 10.3389/fpubh.2024.1424720.
